• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » WIRB-Copernicus Group acquires FDAnews

WIRB-Copernicus Group acquires FDAnews

July 21, 2017
CenterWatch Staff

WIRB-Copernicus Group (WCG), a provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired FDAnews, which provides global regulatory information for executives in the clinical research, biopharmaceutical and medical device industries.

FDAnews joins clinical trial publishing leader CenterWatch to create a powerful new resource for the life science community. FDAnews/CenterWatch provides a suite of well-respected newsletters, books, databases, market intelligence reports, conferences and webinars, including Drug Industry Daily, CenterWatch Monthly, the Clinical Trials Data Library, the Medical Device Quality Congress and the FDA Inspections Summit.

"We are delighted to welcome the accomplished team from FDAnews to our family of companies and excited to see what the combination of FDAnews and CenterWatch will produce for our industry," said Donald A. Deieso, Ph.D., chairman and CEO of WCG. 

"We have long prided ourselves on providing thought leadership and information solutions to the clinical trials community and look forward to extending our offerings to other segments of the biopharmaceutical and medical device ecosystem," said Deieso. "Our clients will benefit from real-time access to regulatory actions, industry developments and other critical issues that affect life sciences organizations."

"We are very excited to join CenterWatch and the family of WCG companies and look forward to what we will collectively deliver to our clients," said Cynthia Carter, president of FDAnews/CenterWatch. "My team has long admired CenterWatch products and we share WCG's mission of providing high-quality products and services to the industry."

Serving the industry for 50 years, WCG is the trusted partner of biopharmaceutical companies, CROs, institutions and central research sites, and has overseen research conducted by 90% of the country's FDA-regulated investigators. Comprised of the largest and most highly accredited institutional review boards (IRBs) in the world, WCG's chief focus is on finding ways to accelerate the clinical research process and protect study volunteers.

Like the other WCG companies, FDAnews/CenterWatch will operate independently as a publishing division within the group and will be respectively located in Falls Church, Virginia and Boston, Massachusetts. WCG will support the new company as it continues to expand with access to capital, expertise and corporate operational support.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing